About the company
Hologic, a leading healthcare company, specializes in manufacturing proprietary products that cater to the unique healthcare needs of women. With a wide range of innovative solutions, Hologic aims to improve the quality of care provided to women across various medical disciplines. The company operates in four distinct segments that contribute to its overall success and growth. The diagnostics segment holds the largest share of Hologic's total sales, constituting approximately 64%. This segment experienced a significant boost in sales during the global pandemic, as the demand for diagnostic testing surged. Hologic's diagnostic products played a critical role in facilitating efficient and accurate testing for various conditions, including COVID-19. The breast health segment, traditionally a key focus for Hologic, accounts for approximately 21% of the company's sales. However, this segment faced suppression during the pandemic due to deferred elective procedures and reduced patient visits to healthcare facilities. Nonetheless, Hologic continues to develop innovative solutions in breast health, aiming to provide women with early detection and treatment options for breast cancer and other related conditions. The surgical segment, contributing approximately 12% of Hologic's sales, focuses on providing innovative technologies and solutions for gynecological procedures and interventions. This segment encompasses products that offer minimally invasive procedures, enabling faster patient recovery and improved outcomes. Hologic's skeletal health segment holds a smaller portion, approximately 2%, of the company's sales. This segment is dedicated to developing and manufacturing advanced technologies for the assessment and management of skeletal health, such as osteoporosis. By offering innovative imaging and diagnostic solutions, Hologic aims to improve the diagnosis and treatment of skeletal-related conditions, promoting better overall patient care. In recent years, Hologic strategically expanded its presence in the diagnostics segment through the acquisition of Gen-Probe. This acquisition not only broadened Hologic's product portfolio but also emphasized the importance of commercial diagnostics within the company's overall operations. Hologic's comprehensive range of commercial diagnostics serves diverse medical disciplines, including infectious diseases, reproductive health, and blood screening, further solidifying the company's position as a leader in this field. When it comes to revenue distribution, the United States represents the largest market for Hologic, accounting for approximately 75% of the company's total revenue. As a Massachusetts-based company, Hologic benefits from its strong presence within the United States, allowing it to effectively serve healthcare providers and patients across the country. While the United States dominates Hologic's revenue distribution, the company also maintains a significant presence in other key markets. Europe accounts for approximately 16% of Hologic's revenue, showcasing the company's commitment to serving the healthcare needs of women globally. Additionally, Asia contributes approximately 6% of Hologic's revenue, highlighting the company's growing presence in rapidly developing healthcare markets. Hologic has also expanded its reach into other international markets, constituting approximately 3% of the firm's revenue. Headquartered in Bedford, Massachusetts, Hologic has established itself as a global leader in women's healthcare. With a strong focus on innovation, the company continues to develop cutting-edge products and technologies that enhance patient care and improve women's health outcomes across the globe. Through its diversified portfolio and strategic acquisitions, Hologic is poised to lead the way in driving advancements in women's health for years to come.
Website: https://www.hologic.com
Data updated: June 2, 2026
